Inclusion on list recognizes Poseida for
employee sentiment and satisfaction
SAN
DIEGO, Oct. 3, 2024 /PRNewswire/ -- Poseida
Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell
therapy and genetic medicines company advancing differentiated
non-viral treatments for patients with cancer and rare diseases,
today announced its inclusion in Newsweek Magazine's annual
America's Top Most Loved Workplaces® list, developed by
Most Loved Workplace®, a division of Best Practice
Institute (BPI).
"At Poseida, our employees are essential to achieving our
mission to boldly develop a new class of cell and gene therapies
with the capacity to cure," said Kristin
Yarema, Ph.D., president and chief executive officer
of Poseida Therapeutics. "This recognition is a testament to
our outstanding and exceptionally talented team at Poseida. It
is an honor to be named to Newsweek's list of top workplaces, which
reflects our strong culture and values combined with our commitment
to our employees, as well as patients."
The results were determined after surveying more than 2.6
million employees from businesses with workforces varying in
size from less than 50 to more than 10,000. The list recognizes
companies that put respect, caring, and appreciation for their
employees at the center of their business model and, in doing so,
have earned the loyalty and respect of the people who work for
them.
How positive employees feel about their future at the company,
career achievement, how much employer values align with employee
values, respect at all levels, and the level of collaboration at
the firm were the five critical areas measured to gauge employee
sentiment. In addition, areas such as inclusion, diversity, equity
and belonging, career development, and company leadership were
identified and analyzed in relation to the five critical areas
measured.
"It's inspiring to see the list expand this year to 200
companies, a clear indication that organizations are truly
committed to creating workplaces where employees feel valued and
connected. We're thrilled to celebrate their achievements as this
recognition continues to grow," said Nancy Cooper, Newsweek's
Global Editor in Chief.
This marks the fourth annual Most Loved Workplace list, and for
2024, the list has expanded to the Top 200, reflecting companies'
growing commitment to prioritizing employee sentiment and creating
workplaces that employees love. Poseida was ranked #140 on the
list. For the full list of the 2024 America's Top 200 Most Loved
Workplaces®, please visit Newsweek.
Methodology
To identify the top 200 companies in this
list, companies were evaluated and scored as follows: 50 percent of
the initial score was based on direct employee responses to BPI's
Love of Workplace Index assessment. 35 percent came from BPI's
direct interviews and written responses from company officials. The
final 15 percent was derived from analysis of external public
ratings from sites such as Comparably, Careerbliss, Glassdoor,
Indeed, and Google. Newsweek then conducted editorial research on
every company before the final list of 200 companies and their
rankings was completed.
About Newsweek
Newsweek is the modern global
digital news organization built around the iconic, over 90-year-old
American magazine. Newsweek reaches 100 million people each month
with its thought-provoking news, opinion, images, graphics, and
video delivered across a dozen print and digital platforms.
Headquartered in New York City,
Newsweek also publishes international editions in EMEA and
Asia.
About Best Practice Institute
Best Practice Institute
is an award-winning leadership and organization development center,
benchmark research company, think tank, and solutions provider. BPI
is the only certifying body for Most Loved Workplace®
and conducted the original research to create the model and
criteria for becoming a Most Loved Workplace®. BPI's
research proves that Most Loved Workplaces® produce 3-4
times better customer service, employee performance, and retention
than companies not loved by their employees.
About Poseida Therapeutics, Inc.
Poseida
Therapeutics is a clinical-stage biopharmaceutical company
advancing differentiated allogeneic cell therapies and genetic
medicines with the capacity to cure certain cancers and rare
diseases. The Company's pipeline includes investigational
allogeneic CAR-T cell therapies for both solid tumors and
hematologic cancers as well as investigational in vivo genetic
medicines that address patient populations with high unmet medical
need. The Company's approach is based on its proprietary genetic
editing platforms, including its non-viral piggyBac® DNA
Delivery System, Cas-CLOVER™ Site-Specific Gene Editing
System, Booster Molecule and nanoparticle gene delivery
technologies, as well as in-house GMP cell therapy manufacturing.
The Company has formed strategic collaborations with Roche and
Astellas to unlock the promise of cell therapies for cancer
patients. Learn more at www.poseida.com and connect
with Poseida on X and LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/poseida-therapeutics-named-to-newsweeks-list-of-the-top-200-americas-most-loved-workplaces-for-2024-302267219.html
SOURCE Poseida Therapeutics, Inc.
